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http://www.biomedcentral.com/1471-2296/13/90RESEARCH ARTICLE Open AccessRandomized controlled trial on cardiovascular risk
management by practice nurses supported by
self-monitoring in primary care
Ans H Tiessen1*, Andries J Smit2, Jan Broer3, Klaas H Groenier1 and Klaas van der Meer1Abstract
Background: Treatment goals for cardiovascular risk management are generally not achieved. Specialized practice
nurses are increasingly facilitating the work of general practitioners and self-monitoring devices have been
developed as counseling aid. The aim of this study was to compare standard treatment supported by
self-monitoring with standard treatment without self-monitoring, both conducted by practice nurses, on
cardiovascular risk and separate risk factors.
Methods: Men aged 50–75 years and women aged 55–75 years without a history of cardiovascular disease or
diabetes, but with a SCORE 10-year risk of cardiovascular mortality ≥5% and at least one treatable risk factor
(smoking, hypertension, lack of physical activity or overweight), were randomized into two groups. The control
group received standard treatment according to guidelines, the intervention group additionally received pro-active
counseling and self-monitoring (pedometer, weighing scale and/ or blood pressure device). After one year
treatment effect on 179 participants was analyzed.
Results: SCORE risk assessment decreased 1.6% (95% CI 1.0–2.2) for the control group and 1.8% (1.2–2.4) for the
intervention group, difference between groups was .2% (−.6–1.1). Most risk factors tended to improve in both
groups. The number of visits was higher and visits took more time in the intervention group (4.9 (SD2.2) vs. 2.6 (SD1.5)
visits p < .001 and 27 (P25 –P75:20–33) vs. 23 (P25 –P75:19–30) minutes/visit p = .048).
Conclusions: In both groups cardiovascular risk decreased significantly after one year of treatment by practice nurses.
No additional effect of basing the pro-active counseling on self-monitoring was found, despite the extra time
investment.
Trial registration: trialregister.nl NTR2188
Keywords: Primary health care, Arteriosclerosis, Cardiovascular diseases, Prevention and control, Self-management, Risk
factorsBackground
Cardiovascular diseases are the most important cause of
death worldwide [1]. Preventive treatment of these dis-
eases is targeted at individuals with an elevated cardio-
vascular risk, based on a combined risk factor approach
[2,3]. However, treatment goals for cardiovascular risk
factors are generally not achieved [4], which underlines* Correspondence: a.h.tiessen@umcg.nl
1Department General Practice, University Medical Centre, Groningen, the
Netherlands
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© 2012 Tiessen et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orthe importance of improving the efficacy of treatment
and follow-up programs.
One of the approaches in the Anglo-Dutch health care
system has been to train specialized practice nurses to
assist the general practitioner (GP). They integrate life-
style counseling and drug treatment according to the
guidelines and achieve promising results, as was shown
in several international studies on cardiovascular risk
management [5-7].
Another development is the use of self-monitoring
(e.g. blood pressure devices, pedometers and standar-
dized weighing scales for use at home) in lifestyle andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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devices has demonstrated improvements on the spe-
cific risk factors [8-11] and in the case of home blood
pressure measurements even led to a decreased use of
medication [12]. Self-monitoring of combined parameters
is already successfully being used in chronic heart failure
patients [13].
The common approach taken in the Anglo-Dutch-
Scandinavian health care system consists of integrated
lifestyle counseling and drug treatment for individuals
with an elevated cardiovascular risk [2,3]. The height of
the risk is estimated based on a combination of different
risk factors (hypertension, hypercholesterolemia, over-
weight, smoking and lack of physical activity) and treat-
ment is aimed at the individual combination of these
risk factors. To our knowledge, no study has yet investi-
gated the combined intervention of this cardiovascular
risk management approach, supported by self-monitoring
equipment, conducted by trained practice nurses in gen-
eral practices, even though such an approach is in line
with the identified developments and might be effective.
The research question that the SPRING study (Self-
monitoring and Prevention of RIsk factors by Nurse
practitioners in the region of Groningen) aimed to an-
swer, was: is cardiovascular risk management according
to the Dutch GP’s Guideline [3], supported by self-moni-
toring, more effective than standard cardiovascular risk
management according to the same guideline, in primary
care? Effectiveness of both treatment strategies was eval-
uated after one year on SCORE (Systematic Coronary
Risk Evaluation) 10-year risk of fatal cardiovascular dis-
ease [14] and on separate risk factors.
Methods
Eligibility criteria for participants
Eligible participants were men aged 50–75 years and
women aged 55–75 years. As women on average start to
have an elevated cardiovascular risk at an older age then
men, age inclusion was adapted to avoid major sex im-
balance in other risk factors. Inclusion furthermore
required a SCORE cardiovascular risk assessment ≥5%
and an indication for treatment for at least one risk fac-
tor (Table 1). Individuals with hypercholesterolemia







* additional risk factors were a SCORE risk assessment ≥ 10%, positive family history
>115-150♂/107-150♀ umol/l, waist circumference >88 cm♀/ >102 cm♂ and BMI >equal for both study groups (Table 2). Exclusion criteria
were: a history of cardiovascular disease, diabetes melli-
tus, thyroid dysfunction or a seriously diminished life ex-
pectancy (estimated <2 years). Written informed consent
was given by all participants. The SPRING study was
approved by the Medical Ethics Review Committee of
the University Medical Centre Groningen (reference
number 2007/232).
Recruitment
20 general practices at 15 locations in the Netherlands
participated. From each practice patient database ap-
proximately 200 individuals meeting age requirements
and without registered exclusion criteria were randomly
selected. The GP excluded individuals with a diminished
life expectancy. Between April and December 2008,
3480 selected individuals received an invitation letter
with a questionnaire (Figure 1). This questionnaire con-
tained items on smoking, BMI >24 kg/m2 and physical
activity <150 minutes/week (2 questions based on the
Short Questionnaire to Assess Health-enhancing Phys-
ical Activity, SQUASH) [15]. Individuals were invited for
the screening if they were interested in participating and
had at least one risk factor. Between June 2008 and
August 2009 a trained research team collected the fol-
lowing screening data at the different practice locations.
Physical examination: Body weight, height and waist
circumference were collected. Blood pressure was mea-
sured two times on each arm and this was repeated on a
different day on the arm with the highest values. The
mean value from this arm was used.
Medical history: Patient reported cardiovascular risk
factors, medication use, medical history and family his-
tory were recorded.
Blood test: After an overnight fast serum glucose,
lipids, thyroid, liver and kidney function were analyzed.
If this suggested diabetes, familial hypercholesterolemia
or thyroid dysfunction, individuals were excluded and
the GP was informed. With other abnormal results it
was decided by mutual agreement with the GP whether
participation was safe or not.
The SCORE risk assessment was calculated based on
sex, age, smoking status, systolic blood pressure and
total/HDL cholesterol, using a computer program (Dutchuideline
Cut off point for recommendation as a treatment goal
BMI ≥25 kg/m2 or waist circumference >80 cm♀/>94 cm♂
≥1 item/day
<30 minutes moderately intensive physical activity on ≥5 days/week
systolic blood pressure ≥140 mmHg and ≥1 additional risk factor*
LDL >2,5 mmol/l and ≥1 additional risk factor*
for cardiovascular disease (<60 years in first degree relative), serum creatinine.
30 kg/ m2.
Table 2 Treatment programs and follow-up schedules for the different risk factors in both treatment groups
Risk factor Control group Intervention group
Overweight  One single advice + standard information leaflet from
Dutch GP society.
 Intensive counseling and feedback on energy intake and
expenditure, supported by food diary, home weight scale
(Microlife WS 80), step diary and pedometer (Yamax
digiwalker SW-200).
 More counseling or referral only
on patient’s request
 Follow-up 3 times at monthly intervals and after that at
3-monthly intervals.
Smoking  One single advice + standard information leaflet from
Dutch GP society.
 Intensive counseling and feedback based on Stage of
Change, Minimal Intervention Strategy and Dutch GP
guideline.
 More counseling or referral only
on patient’s request
 Follow-up monthly until planned date of quitting and after
that at increasing intervals.
Physical inactivity*  One single advice + standard information leaflet from
Dutch GP society.
 Intensive counseling and feedback on increasing physical
activity, supported by step diary and pedometer
(Yamax digiwalker SW-200).
 More counseling or referral only
on patient’s request
 Follow-up 3 times at monthly intervals en after that
at 3-monthly intervals.
Hypertension Medication and follow-up according to Dutch
GP guideline. Follow-up: monthly
(hypert.) /3-monthly (hyperchol.)
until optimal treatment.
Same as control group except feedback based on home
measurements (Microlife Watch BP Home).
Hypercholesterolemia Same as control group.
* If participants also had an indication to lose weight, increase of physical activity was not a separate goal.
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is the maximum age for this risk calculator and was used
for all participants aged ≥ 65 years. Treatment goals were
individually determined (Table 1), based on risk factors,
irrespective of current medication. Baseline data con-
sisted of screening data, completed with a questionnaire,
containing items on general characteristics and the stan-
dardized RAND-36 health survey and SQUASH [15,16].
Participants were allocated 1:1 to two parallel unpaired
treatment groups, using computer generated random
numbers. Randomization was at patient level.
Intervention
General practices could participate if a practice nurse
was working in the practice, which is the most current
situation in Dutch general practices (2006: 70% of the
practices) [17]. Practices were located in the northern
part of the Netherlands, both at the city of Groningen
and in smaller cities/villages. Fourteen practice nurses
participated; ten of them were educated as nurses and
four were originally GP-assistants with additional educa-
tion as practice nurse. The practice nurses followed a
specially developed training program, consisting of five
sessions lasting four hours each. The training involved
cardiovascular risk calculation, treatment guidelines and
adapted motivational interviewing. Motivational inter-
viewing is “a collaborative, person-centered form of
guiding to elicit and strengthen motivation for change”
[18]. This method, in which a client’s readiness to change,
ambivalence and motivation are assessed and goal set-
ting and changing of unhealthy behavior are reinforced,
in collaboration with the client, has proven to beeffective in various settings [18-21]. Closely related to
this is the stage-of-change concept, which is used in
the minimal intervention strategy for smoking cessation
[22,23].
All patients received counseling regarding cardiovas-
cular risk from practice nurses trained in motivational
interviewing techniques and in the intervention group
this counseling was based on self-monitoring results
(pedometer, weighing scale and/ or blood pressure de-
vice). Table 2 shows treatment and follow-up programs
for both study groups. Visits took place at the general
practices. During the first visit, the individual SCORE
risk assessment, present risk factor(s) and resulting treat-
ment goals were discussed in both groups.
For the control group, follow-up visits were planned
according to the Dutch GP guideline in case of hyper-
tension and/or hypercholesterolemia [3].
For the intervention group, treatment for all present
risk factors was pro-actively offered. The order in which
the treatments for the different risk factors were started
depended on preference and stage of change of the par-
ticipant. Adapted motivational interviewing was used to
help participants recognize and change unhealthy behav-
ior. If applicable, quitting smoking was advised as the
first treatment goal. Treatment for all risk factors that
the participant was motivated for working on, had to
start within three months. In case of several risk factors,
these treatments could be combined within one visit.
The first visit was advised to take at least 20 minutes,
while the duration of follow-up visits and follow-up in-
tervals could be adapted to patient preferences. Depen-
dent on the specific individual risk factor(s), participants
Figure 1 Flow of patients through the SPRING study.
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ample, all participants with overweight were offered a
weighing scale and pedometer at home. The use of self-
monitoring was free of charge.
For both groups, medication adjustments were made
by the practice nurses under supervision of the GP. For
each visit the practice nurses filled in a step by step
treatment plan based on the Dutch GP guideline.
Outcomes
After one year anthropometric data, information on
smoking behavior, changes in medication and medical
history, fasting blood glucose, lipids and creatinine were
collected. The baseline questionnaire was repeated and
treatment plans were analyzed on the number and dur-
ation of visits and use of self-monitoring. For the calcu-
lation of the SCORE risk assessment both at baseline
and after one year, the age at baseline was used, entailing
slight underestimation of the risk after one year.
Statistical analysis
Based on two earlier studies, a difference between both
study groups of 2% in SCORE risk assessment was
assumed [24,25]. After screening of the first 82 partici-
pants in January 2009, the observed standard deviation
was 3.3. Power analysis with a standard deviation of 4
revealed that 86 subjects in each study arm were needed
for 90% power and 5% significance level 2-sided. To
allow for drop out we aimed to enroll at least 200
participants.
Data were analyzed for all participants that attended
the data collection after one year. Baseline charac-
teristics in both treatment groups, characteristics of par-
ticipants and drop-outs, and characteristics of the
treatment in both groups were evaluated with unpaired
Student’s t-test for continuous variables and with
Mann–Whitney U test when non-parametric testing was
indicated. Normality of data was assessed by visual ana-
lysis of histograms and QQ-plots. Categorical variables
were analyzed with Fisher’s exact test 2-sided. Change in
risk profile after one year was analyzed with paired t-test
for continuous variables and McNemar test for dichot-
omous variables. To compare the effects after one year
in both groups, unpaired t-test was used for continuous
variables and the difference in proportions for the other
variables. We used statistical package SPSS version 16. A
p-value < .05 was considered significant.
Results
Figure 1 shows the flow of patients through the SPRING
study. The drop-out level was 11%; 6% in the control
group and 15% in the intervention group (p = .045).
Figure 1 also shows reasons for drop-out.Table 3 shows that during baseline measurements both
groups were well balanced with no significant differences
between groups. All p-values were > .1, except for HDL
cholesterol and total cholesterol/HDL ratio, which tended
to be higher in the intervention group (p = .068 and
p = .071 respectively).
We compared drop-outs with participants completing
follow-up on these similar variables. No significant dif-
ferences were found between drop-outs and participants,
except for waist circumference (107 cm (SD 12) for
drop-outs and 102 cm (SD 10) for participants, p = .011).
The treatment period (from the first visit to the prac-
tice nurse until the outcome measurements) lasted
345 days (SD 76 days), and was not different for inter-
vention and control group (p = .81). The time between
baseline measurements/ randomization and first treat-
ment visit was 97 days (median, P25 –P75: 65–125) and
was not different between both groups (p = .25).
The mean number of visits was 2.6 (SD 1.5) for the
control group and 4.9 (SD 2.2) for the intervention
group (p < .001) and the median duration of each visit
was 27 (P25 –P75:20–33) minutes/visit for the interven-
tion group and 23 (P25 –P75:19–30) for the control
group (p = .048).
In the intervention group 15.7% (14/89) received new/
more medication for hypercholesterolemia, compared to
8.9% (8/90) of the control group. In the intervention
group 32.6% (29/89) received new/more medication for
hypertension, compared to 18.9% (17/90) of the control
group. The difference in medication prescription was
not significant for cholesterol (p = .18), but was signifi-
cant for hypertension (p = .041).
Table 4 shows that for both groups the SCORE risk as-
sessment dropped significantly after one year, however
the difference between both treatment groups was not
significant. The effect on the SCORE assessment was
also evaluated using risk category reclassification. In
both groups almost 50% of the participants remained in
the same risk category, 44% improved and 8% deterio-
rated. From the analysis of the risk reclassification again
no significant difference between both groups was
found. Most separate risk factors tended to improve
after one year in both groups, except glucose. Only for
waist circumference, the intervention group showed a
significantly larger improvement than the control group.
Discussion
Main findings
The goal of the SPRING study was to investigate the ef-
fect of one year of risk management performed by prac-
tice nurses, using intensive counseling and home
monitoring devices, on cardiovascular risk. The results
of the study show that there was no significant add-
itional effect of this intervention compared to standard
Table 3 Baseline characteristics for both treatment groups, n (%) unless otherwise indicated
Control group N=90 Intervention group N=89
General characteristics:
Age (years), M (SD) 65 (5.7) 65 (5.3)
Men 61 (68%) 63 (71%)
Level of education (level 1–4)*
Level 1 (%) 9% 10%
Level 2 (%) 40% 45%
Level 3 (%) 30% 24%
Level 4 (%) 22% 21%
Medication use:
Medication for hypertension 23 (26%) 26 (29%)
Medication for hypercholesterolemia 10 (11%) 5 (6%)
Cardiovascular risk factors:
Current smokers 30 (33%) 27 (30%)
Physically inactive participants 28 (32%) 23 (27%)
BMI (kg/m2), M (SD) 29 (4.0) 28 (3.3)
Waist circumference (cm), M (SD) 102 (10.8) 101 (8.0)
Syst. blood pressure (mmHg), M (SD) 158 (16.3) 158 (17.1)
Diast. blood pressure (mmHg), M (SD) 91 (8.5) 92 (9.5)
Blood test (after overnight fast):
Total cholesterol (mmol/l), M (SD) 5.6 (.94) 5.6 (.85)
HDL cholesterol (mmol/l), M (SD) 1.3 (.34) 1.3 (.29)
LDL cholesterol (mmol/l), M (SD) 3.6 (.81) 3.6 (.78)
Triglycerides (mmol/l), median (P25 –P75) 1.4 (1.02-1.76) 1.4 (1.06-2.15)
Total cholesterol/HDL ratio, M (SD) 4.4 (1.11) 4.7 (1.11)
Glucose (mmol/l), M (SD) 5.4 (.68) 5.4 (.50)
Creatinine (mmol/l), M (SD) 91 (16.8) 89 (17.6)
SCORE risk calculation:
SCORE (%), median (P25 –P75) 7.19 (5.23-10.64) 7.58 (6.08-10.63)
Treatment indication:
Treatment goals/person, median (P25 –P75) 3 (3–4) 3 (3–4)
Overweight 86 (96 %) 87 (98 %)
Smoking 30 (33 %) 27 (30 %)
Physical inactivity 29 (32 %) 24 (27 %)
Hypertension 70 (78 %) 67 (75 %)
Hypercholesterolemia 73 (81 %) 69 (76 %)
inactive: physical activity < 30 min./day on 5 d./w, based on the SQUASH questionnaire, which was completed by 89 controls and 85 intervention participants.
For missing data, treatment indication was based on the 2 questions about physical activity from the invitation letter.
* Level of education: 1 = no education or only primary education 2 = lower secondary education, 3 = higher secondary education, 4 = college or university.
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time. For both groups the SCORE risk assessment
dropped similarly and significantly. The effect size is
comparable to a decrease in systolic blood pressure from
160 to 120 mmHg for a non-smoking 60-year old
woman with unchanged lipid levels.
Comparison with existing literature
The positive effect that was achieved in both study
groups after treatment of risk factors by practicenurses corresponds with previous research on cardio-
vascular risk management by practice nurses [5-7].
Effective treatment and follow-up are increasingly
necessary as improved screening strategies like the
recently introduced Dutch Prevention Consultation
and similar initiatives elsewhere, such as the NHS
Health Checks, have been developed [26,27]. Because
of these screening initiatives, increasing numbers of
individuals with an identified elevated cardiovascular
risk are expected.
Table 4 Effect on end points after one year of treatment
Control group N=90 Intervention group N=89 Difference between groups (95% CI)
SCORE risk assessment:
SCORE (%) −1.6 (−2.2– -1.0)* −1.8 (−2.4– -1.2)* .2 (−.6–1.1)
Risk reclassification:
No change 42 (46.7 %) 44 (49.4 %) 2.7 (−11.9–17.3)
Improvement 41 (45.6 %) 37 (41.6 %) 4.0 (−10.5–18.5)
Deterioration 7 (7.8 %) 8 (9.0 %) 1.2 (−6.9–9.3)
Cardiovascular risk factors:
Current smokers (Δ%) −8.9 (−16.8– -3.9)*† −11.2 (−19.7– -5.5)*† 2.3 (−6.5–11.1)
Phys. inactive participants (Δ%) −4.5 (−11.2– -1.3)† −11.8 (−20.6– -5.8)† 7.3 (−.8–15.4)
BMI (kg/m2) -.1 (−.41–.28) -.1 (−.38– .17) .04 (−.4–.5)
Waist circumference (cm) −1.9 (−3.1– -.67)* −3.7 (−4.8– -2.6)* 1.8 (.2–3.4)*
Syst. blood pressure (mmHg) −5.6 (−8.5– -2.6)* −6.8 (−10.3– -3.2)* 1.2 (−3.4–5.8)
Diast. blood pressure (mmHg) −3.3 (−4.8– -1.8)* −4.4 (−6.3– -2.4)* 1.1 (−1.4–3.5)
Blood test:
Total cholesterol (mmol/l) -.14 (−.31–.03) -.32 (−.52– -.11)* .17 (−.09–.44)
HDL cholesterol (mmol/l) .10 (.05–.14)* .07 (.03–.11)* .02 (−.04–.08)
LDL cholesterol (mmol/l) -.18 (−.34– -.02)* -.34 (−.52– -.16)* .16 (−.08–.39)
Triglycerides (mmol/l) -.07 (−.18–.04) -.17 (−.32– -.03)* .10 (−.08–.28)
Tot. cholesterol/HDL ratio -.34 (−.50– -.18)* -.52 (−.73– -.32)* .18 (−.08–.44)
Glucose (mmol/l) .28 (.15–.41)* .17 (.06–.29)* .11 (−.07–.28)
Creatinine (mmol/l) −6.0(−8.2– -3.7)* −5.1 (−7.2– -2.9)* -.9 (−4.0–2.2)
* significant
† McNemar’s test in dichotomous variables: Δ% current smokers: control group p= .008, intervention group p= .006; Δ% physically inactive participants: control
group p= .54, intervention group p= .052.The questionnaire about physical activity after one year was completed by 89 participants from the control group and
89 participants from the intervention group. The 85 participants from the intervention group and the 88 participants from the control group that completed the
questionnaire twice were analyzed.
Effects are indicated as delta values in continuous variables and Δ % in dichotomous variables, both with 95% CI. Risk reclassification is indicated as n (%) in both
groups and as % in difference between groups.
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one year of treatment, this was not the case for fasting
glucose levels and body mass index (BMI). A possible
explanation is that the participants belong to a middle
aged, adipose population with an elevated risk of glucose
intolerance. After one year the glucose might rise slightly
due to increase of age. Besides, the focus of this study
was on combined cardiovascular risk and not on weight
only [28]. Another explanation is the prescription of
antihypertensive medication; beta blocking agents and
diuretics increase the risk of incident diabetes [29].
In the intervention group antihypertensives were more
often newly added or the dosage was increased, com-
pared to the control group. A similar trend was present
for cholesterol lowering medication. The treatment pro-
grams for hypertension and hypercholesterolemia were
the same for both groups, except for the use of home
monitoring in blood pressure management for the inter-
vention group. However, decreased use of medication in
the intervention group might have been expected, be-
cause of reduced white coat effect and more feedback
and subsequent adherence to therapy [12]. One possible
explanation is that the target blood pressure values were135/85 mmHg for home measured values in this study,
compared to 140/90 mmHg for office measured values.
Another explanation is that during visits for lifestyle
counseling in the intervention group, blood pressure and
lipid levels could also be discussed. As a consequence,
medication may have been adjusted more frequently.
Strengths and limitations
As far as we know, this is the first study that investigated
the effect of combined pro-active counseling aided by
self-monitoring devices by practice nurses in general
practice.
Some circumstances may explain the decrease in
SCORE assessment in both groups and the minor differ-
ences that were found between both study groups. First,
we randomized at patient level instead of practice level,
with the result that participants from both groups were
treated by the same practice nurses. Randomization at
patient level was chosen to diminish the influence of dif-
ferences between practices c.q. practice nurses. Another
advantage was that it made the study more efficient,
since individuals were the unit of analysis and only a
limited number of practices was required with this
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were very motivated. The fact that the time investment
in the intervention group was much higher, made us ex-
pect that contamination of research conditions would be
limited. However, some degree of contamination might
be present and may have diminished the difference be-
tween both groups.
Second, participants in both treatment groups were
aware of the study goals and were probably more moti-
vated than average patients.
For example the remarkably large decrease in propor-
tions of smokers in both groups suggests the influence
of these factors.
The intervention was an integrated combination of
self-monitoring and a more pro-active and motivational
interviewing-based approach. The two group design
made it impossible to determine the separate influence
of these specific aspects of the intervention.
The drop-out rate was 6% in the control group and
15% in the intervention group. The reasons for drop-out
as represented in Figure 1 do not indicate that the in-
tensity of the program has been the main reason for in-
creased drop-out in the intervention group. However,
the precise extent to which the intensity of the program
contributed to the dropping-out of persons with non-
cardiovascular comorbidity, family related circumstances
or lack of motivation in the intervention group is un-
known, although the intensity of the intervention pro-
gram was intended to be adjusted in accordance with
the participants’ preferences, to optimize involvement
and motivation.
During the screening procedure a considerable num-
ber of individuals was excluded, due to the extensive
amount of information that needed to be collected for
identifying individuals at a moderately elevated cardio-
vascular risk. We nevertheless expect our results to be
applicable for a primary care population with an indica-
tion for cardiovascular risk management.
During the screening we used a risk calculator, pro-
vided by the Dutch GP Society. For the analyses we used
syntax to calculate SCORE with 2 decimals accuracy.
Using this latter calculation, 10 (11%) participants from
the intervention group and 16 (18%) from the control
group appeared to have a baseline risk <5%. Normally
treatment is based on paper-based risk charts or the cal-
culator we used, so our selection represents the patients
that would also be identified during normal practice.
Conclusions
Based on this study, we confirm previous findings that
practice nurses in general practice are well equipped for
their task to treat and counsel individuals with an ele-
vated cardiovascular risk. However, the intervention
group did not achieve a better effect on cardiovascularrisk, which suggests that the treatment program based
on self-monitoring should not be directly implemented
into daily practice. The time investment is greater in such
a program and the number of prescribed medications
tends to be higher, without any relevant additional effect,
but with subsequent higher risk of side effects. Factors
determining the effect of self-monitoring have to be fur-
ther unveiled, as well as consequences for health care
costs and long term effects on morbidity and mortality.
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